ENDEFR
Home › Denmark › XELLIA PHARMACEUTICALS ApS

XELLIA PHARMACEUTICALS ApS

Anpartsselskab (ApS) · København S, Denmark · LEI 549300QZH7QG20ETC156
LEI active

Summary

XELLIA PHARMACEUTICALS ApS is registered in Denmark and entered in the “Central Business Register (CVR)” under number 61094628. Its legal form is Anpartsselskab (ApS) – private limited company (Denmark). According to GLEIF, its ultimate parent is Novo Nordisk Fonden (Denmark). That group has 8 subsidiaries with LEIs in 2 countries, 4 of them in Denmark. The LEI was first issued on 28 Aug 2014 and the record was last updated on 29 Sep 2026; the next renewal is due by 10 Oct 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAnpartsselskab (ApS)
private limited company (Denmark)
RegisterCentral Business Register (CVR) · Register website
Registration number61094628
Registration authorityDanish Business Authority
JurisdictionDenmark
Registered addressDalslandsgade 11, 2300 København S, Denmark
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)31 Mar 1959
LEI549300QZH7QG20ETC156
LEI statusactive
LEI first issued28 Aug 2014
LEI record last updated29 Sep 2026
Next LEI renewal10 Oct 2027
Corroboration of the LEI recordfully corroborated

Group membership

Novo Nordisk Fonden Denmark lapsed ultimate parent
XELLIA PHARMACEUTICALS ApS this entity
View the whole group: 8 subsidiaries in 2 countries

Relationship to the parent

Ultimate parent
ParentNovo Nordisk Fonden
Accounting period31 Dec 2024 to 30 Dec 2025
Evidencesupporting documents
Corroborationfully corroborated
Relationship start12 Aug 2024
Recorded at GLEIF since12 Aug 2024
Last updated29 Sep 2026
Record statuscurrent

Parent not reported to GLEIF

  • Direct parent: the parent has no LEI and has not consented to obtain one.

Other names

  • AXELLIA PHARMACEUTICALS ApS · previous name
  • Alpharma ApS · previous name